By Tom Zanki ( October 25, 2017, 3:57 PM EDT) -- Belgian biotechnology company Ablynx NV said Wednesday it raised $200 million in an upsized U.S. initial public offering, completing a cross-border deal that engaged the services of four law firms....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.